On Friday, A.P. Moller Holding revealed plans pertaining to the acquisition of laboratory diagnostics firm Unilabs. However, the arrival of the major investment firm does not herald change for the life science industry.
According to Chief Investment Officer at A.P. Moller Holding Jan T. Nielsen, Unilabs's infrastructure – not the life science industry itself – was what drew the firm's attention.
More from MedWatch
Experiences from Danish climate partnerships are among the tools that can be leveraged when Novo Nordisk CEO Lars Fruergaard begins stepping up efforts in the life science sector’s central organs in Brussels. ”I’ve been fired up by the intimacy and shared vision we could see in Denmark,” he tells MedWatch.